Skip to Content

Tag: Harvard Drug Group

Specialty Providers

Market outlook

January 26, 2010Theresa Flaherty, Managing Editor

YARMOUTH, Maine - Has the topsy-turvy world of respiratory medications turned a corner? Wayne Vega thinks so. The vice president of sales for Harvard Drug Group says 2010 could shape up to be "an exceptional year." Here's what he had to say: The players Small and mid-sized pharmacies are exiting the business but nationals like Lincare are no longer buying those patients. Instead, we're seeing what we call hypernationals--someone that has a significant volume and patient base yet doesn't necessarily...

Harvard Drug Group, respiratory medications, Wayne Vega

Read Full Articlered right arrow icon